skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation
Material Type:
Article
Add to My Research

CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation

Journal of neuroinflammation, 2020-02, Vol.17 (1), p.48-48, Article 48 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1742-2094 ;EISSN: 1742-2094 ;DOI: 10.1186/s12974-020-1727-6 ;PMID: 32019570

Full text available

2
MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells
Material Type:
Article
Add to My Research

MicroRNA-148a/b-3p regulates angiogenesis by targeting neuropilin-1 in endothelial cells

Experimental and Molecular Medicine, 2019, 51(0), , pp.1-11 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1226-3613 ;EISSN: 2092-6413 ;DOI: 10.1038/s12276-019-0344-x ;PMID: 31723119

Full text available

3
Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
Material Type:
Article
Add to My Research

Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model

Fluids and barriers of the CNS, 2023-02, Vol.20 (1), p.9-9, Article 9 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-8118 ;EISSN: 2045-8118 ;DOI: 10.1186/s12987-023-00410-x ;PMID: 36726154

Full text available

4
Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
Material Type:
Article
Add to My Research

Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury

Journal of inflammation (London, England), 2023-04, Vol.20 (1), p.13-13, Article 13 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1476-9255 ;EISSN: 1476-9255 ;DOI: 10.1186/s12950-023-00338-x ;PMID: 37024954

Full text available

5
A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway
Material Type:
Article
Add to My Research

A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway

Frontiers in pharmacology, 2023-11, Vol.14, p.1275749-1275749 [Peer Reviewed Journal]

Copyright © 2023 Park, Zhang, Kwak, Gadhe, Kim, Kim, Noh, Shin, Ha and Kwon. 2023 Park, Zhang, Kwak, Gadhe, Kim, Kim, Noh, Shin, Ha and Kwon ;ISSN: 1663-9812 ;EISSN: 1663-9812 ;DOI: 10.3389/fphar.2023.1275749

Full text available

6
CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury
Material Type:
Article
Add to My Research

CU06-1004 enhances vascular integrity and improves cardiac remodeling by suppressing edema and inflammation in myocardial ischemia-reperfusion injury

Experimental and Molecular Medicine, 2022, 54(0), , pp.1-12 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1226-3613 ;EISSN: 2092-6413 ;DOI: 10.1038/s12276-021-00720-w ;PMID: 34997212

Full text available

7
CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice
Material Type:
Article
Add to My Research

CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice

Journal of pharmacological sciences, 2024-02, Vol.154 (2), p.77-85 [Peer Reviewed Journal]

Copyright © 2024 The Authors. Production and hosting by Elsevier B.V. All rights reserved. ;ISSN: 1347-8613 ;EISSN: 1347-8648 ;DOI: 10.1016/j.jphs.2023.12.009 ;PMID: 38246731

Full text available

8
CANCER IMMUNOTHERAPHY ADJUVANT
Material Type:
Patent
Add to My Research

CANCER IMMUNOTHERAPHY ADJUVANT

Digital Resources/Online E-Resources

9
Adjuvant for cancer immunotherapy
Material Type:
Patent
Add to My Research

Adjuvant for cancer immunotherapy

Digital Resources/Online E-Resources

10
Cancer Immunotherapy Adjuvant
Material Type:
Patent
Add to My Research

Cancer Immunotherapy Adjuvant

Digital Resources/Online E-Resources

11
CANCER IMMUNOTHERAPHY ADJUVANT
Material Type:
Patent
Add to My Research

CANCER IMMUNOTHERAPHY ADJUVANT

Digital Resources/Online E-Resources

12
CANCER IMMUNOTHERAPHY ADJUVANT
Material Type:
Patent
Add to My Research

CANCER IMMUNOTHERAPHY ADJUVANT

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (7)

Refine My Results

Creation Date 

From To
  1. Before 2019  (1)
  2. 2019 To 2019  (1)
  3. 2020 To 2020  (3)
  4. 2021 To 2022  (4)
  5. After 2022  (4)
  6. More options open sub menu

Resource Type 

  1. Articles  (7)
  2. Patents  (5)
  3. More options open sub menu

Language 

  1. French  (3)
  2. German  (2)
  3. Korean  (2)
  4. More options open sub menu

Searching Remote Databases, Please Wait